Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study

By Gridelli C.   Perrone F.   Gallo C.   De Marinis F.   Ianniello G.   Cigolari S.   Cariello S.   Di Costanzo F.   D'Aprile M.   Rossi A.   Migliorino R.   Bartolucci R.   Bianco A.R.   Pergola M.   Monfardini S.  

European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. : 392-397

Elsevier

Access to resources Recommend Favorite

Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer

By Baron F.   Cueva J.   Grana B.   Curiel T.   Leon L.   Vazquez F.   Candamio S.   Lopez R.  

European Journal of Cancer, Vol. 37, Iss. 11, 2001-07 ,pp. : 1381-1384

Elsevier

Access to resources Recommend Favorite

Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer

By Maestu I.   Gomez-Aldaravi L.   Torregrosa M.D.   Camps C.   Llorca C.   Bosch C.   Gomez J.   Giner V.   Oltra A.   Albert A.  

Lung Cancer, Vol. 42, Iss. 3, 2003-12 ,pp. : 345-354

Elsevier

Access to resources Recommend Favorite

Vinorelbine, Ifosfamide and Cisplatin in Advanced Non-Small Cell Lung Cancer

By Tan Eng-Huat   Ang Peng Tiam   Wee Joseph   Fong Kam Weng   Leong Swan Swan   Khoo Kei Siong  

Acta Oncologica, Vol. 38, Iss. 5, 1999-06 ,pp. : 619-622

Informa Healthcare

Access to resources Recommend Favorite

A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancer

By Bennouna J.   Monnier A.   Riviere A.   Milleron B.   Lemarie E.   Trillet-Lenoir V.   Soussan-Lazard K.   Berille J.   Douillard J.Y.  

European Journal of Cancer, Vol. 36, Iss. 9, 2000-06 ,pp. : 1107-1112

Elsevier

Access to resources Recommend Favorite